GENCLIS
Genclis SA is a biotechnology company focused on developing therapies for both human and animal health using Transcription Infidelity (“TI”). TI is a patented process that begins by analyzing differences between RNA and DNA sequences to identify translated proteins capable of causing the production of either Immunoglobulin E (“IgE”), the antibody responsible for most forms of allergies or Immunoglobulin G (“IgG”), the workhorse of immunity that accounts for most of vaccine efficacy. Genclis uses its proprietary patented platform technology to develop therapies that elicit self-produced antibodies that block disease-causing proteins irrespective of their endogenous or exogenous origin.
GENCLIS
Industry:
Biotechnology Health Care
Founded:
2004-01-01
Address:
Nancy, Lorraine, France
Country:
France
Website Url:
http://www.genclis.com
Total Employee:
11+
Status:
Active
Contact:
+33 3 83 67 82 11
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Egle Therapeutics
Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.
Current Employees Featured
Official Site Inspections
http://www.genclis.com
- Host name: node45-eu.n0c.com
- IP address: 185.221.182.59
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
